Australia markets close in 5 hours 48 minutes

Novartis AG (NVS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
89.84-2.97 (-3.20%)
At close: 04:00PM EST
89.80 -0.04 (-0.04%)
After hours: 05:48PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 198.40B
Enterprise value 207.83B
Trailing P/E 9.49
Forward P/E 14.43
PEG ratio (5-yr expected) 5.65
Price/sales (ttm)3.91
Price/book (mrq)3.26
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.49
52-week change 39.01%
S&P500 52-week change 3-7.17%
52-week high 394.26
52-week low 374.09
50-day moving average 389.86
200-day moving average 385.36

Share statistics

Avg vol (3-month) 31.99M
Avg vol (10-day) 32.02M
Shares outstanding 52.15B
Implied shares outstanding 6N/A
Float 82.06B
% held by insiders 10.01%
% held by institutions 18.50%
Shares short (29 Dec 2022) 44.79M
Short ratio (29 Dec 2022) 42.72
Short % of float (29 Dec 2022) 4N/A
Short % of shares outstanding (29 Dec 2022) 40.22%
Shares short (prior month 29 Nov 2022) 45.29M

Dividends & splits

Forward annual dividend rate 43.33
Forward annual dividend yield 43.61%
Trailing annual dividend rate 33.39
Trailing annual dividend yield 33.65%
5-year average dividend yield 43.55
Payout ratio 434.28%
Dividend date 316 Mar 2022
Ex-dividend date 407 Mar 2022
Last split factor 21116:1000
Last split date 308 Apr 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 41.71%
Operating margin (ttm)27.17%

Management effectiveness

Return on assets (ttm)7.41%
Return on equity (ttm)36.99%

Income statement

Revenue (ttm)52.26B
Revenue per share (ttm)23.68
Quarterly revenue growth (yoy)-3.90%
Gross profit (ttm)37.44B
Net income avi to common (ttm)21.8B
Diluted EPS (ttm)9.70
Quarterly earnings growth (yoy)-43.00%

Balance sheet

Total cash (mrq)19.01B
Total cash per share (mrq)8.84
Total debt (mrq)28.54B
Total debt/equity (mrq)46.86
Current ratio (mrq)1.31
Book value per share (mrq)28.27

Cash flow statement

Operating cash flow (ttm)14.01B
Levered free cash flow (ttm)13B